Major GoodRx (NASDAQ: GDRX) holder reshapes stake via conversion and sale
Rhea-AI Filing Summary
GoodRx Holdings, Inc. (GDRX) is the subject of an amended Schedule 13D filed by a group of Francisco Partners entities updating their ownership and recent transactions. The group reports beneficial ownership of 52,578,184 Class B shares, convertible one-for-one into Class A, representing 32.9% of Class A on an as-converted basis, assuming 159,759,385 Class A shares outstanding.
On August 20, 2026, Francisco Partners IV, L.P. and Francisco Partners IV-A, L.P. converted 4,995,903 and 2,504,097 Class B shares into Class A shares and distributed in kind 3,596,648 and 1,142,357 Class A shares, respectively, pro rata and for no consideration to their partners. The remaining 2,743,043 Class A shares from this conversion were sold by affiliated entities for aggregate consideration of $9,678,731.4997, with proceeds distributed to partners. Voting and dispositive power over the position is shared among several Francisco Partners management and general partner entities, which may be deemed to share beneficial ownership but disclaim it.
Positive
- None.
Negative
- None.
Filing Explained
For the 60 days covered by this amendment, the reporting persons disclose no Class A transactions other than the August 20, 2026 distribution and sales described in the filing, narrowing the reported transaction history to those events.
Key Figures
Key Terms
Schedule 13D regulatory
beneficially owned financial
distributed in kind financial
aggregate consideration financial
Stockholders Agreement regulatory
dispositive power financial
FAQ
What ownership in GDRX does Francisco Partners report in this Schedule 13D/A?
AI-generated analysis. How Rhea-AI works. Not financial advice.